Key Points
- CEO Sean Duffy sold 4,063 shares on March 9 at an average price of $14.34 for about $58,263, reducing his stake by 3.34% to 117,598 shares (worth roughly $1.69M).
- Omada beat expectations for the quarter, reporting $0.08 EPS versus a consensus of ($0.04) and revenue of $75.85 million.
- Analysts are cautiously positive with a consensus "Moderate Buy" rating and a $22.90 price target, while the stock trades near $13.78 with a market cap of about $812M and a negative P/E (~-81).
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 4,063 shares of the firm's stock in a transaction on Monday, March 9th. The shares were sold at an average price of $14.34, for a total transaction of $58,263.42. Following the sale, the chief executive officer owned 117,598 shares in the company, valued at $1,686,355.32. The trade was a 3.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Omada Health Trading Up 0.3%
Omada Health stock traded up $0.04 during mid-day trading on Thursday, hitting $13.78. The stock had a trading volume of 197,894 shares, compared to its average volume of 1,369,728. Omada Health, Inc. has a one year low of $10.28 and a one year high of $28.40. The firm has a market capitalization of $811.92 million and a P/E ratio of -81.06. The firm's 50 day moving average is $13.93 and its 200 day moving average is $18.52.
Omada Health (NASDAQ:OMDA - Get Free Report) last announced its quarterly earnings data on Thursday, March 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.12. The business had revenue of $75.85 million during the quarter.
Wall Street Analysts Forecast Growth
OMDA has been the subject of several recent analyst reports. Barclays dropped their price target on Omada Health from $22.00 to $17.00 and set an "overweight" rating for the company in a research note on Tuesday, March 3rd. The Goldman Sachs Group reissued a "buy" rating and issued a $26.00 target price on shares of Omada Health in a report on Friday, January 16th. Wells Fargo & Company began coverage on shares of Omada Health in a research report on Thursday, January 8th. They set an "equal weight" rating and a $17.00 target price for the company. BMO Capital Markets reduced their price target on shares of Omada Health from $27.00 to $18.00 and set an "outperform" rating on the stock in a report on Friday, March 6th. Finally, Canaccord Genuity Group decreased their price target on shares of Omada Health from $28.00 to $22.00 and set a "buy" rating on the stock in a research note on Friday, March 6th. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $22.90.
Read Our Latest Stock Analysis on OMDA
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the company. Quarry LP purchased a new position in shares of Omada Health in the fourth quarter valued at $29,000. TD Waterhouse Canada Inc. bought a new position in Omada Health during the fourth quarter valued at $32,000. Raymond James Financial Inc. purchased a new position in shares of Omada Health in the 2nd quarter worth $32,000. Strs Ohio bought a new stake in shares of Omada Health in the 3rd quarter worth about $38,000. Finally, Inlight Wealth Management LLC purchased a new stake in shares of Omada Health during the 4th quarter valued at about $45,000.
Omada Health Company Profile
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
